<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03043183</url>
  </required_header>
  <id_info>
    <org_study_id>ERAS AND Nutritional Status</org_study_id>
    <nct_id>NCT03043183</nct_id>
  </id_info>
  <brief_title>Enhanced Recovery After Surgery(ERAS) for Gastric Cancer and Perioperative Nutritional Status</brief_title>
  <official_title>The Effect of Perioperative Nutritional Status on Enhanced Recovery After Surgery for Gastric Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Hospital of Jilin University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Hospital of Jilin University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a prospective, single-center, randomized controlled trial. The study protocol
      was approved by the Ethics Committee at the First Hospital of Jilin University.The
      perioperation nutritional status will be assessed in gastric cancer patients within ERAS
      protocols.The ERAS patients were randomly divided into perioperational nutrition support
      group and conventional pathway group . Inter-group differences were evaluated for nutritional
      index,clinical recovery index, complications etc.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2017</start_date>
  <completion_date type="Anticipated">September 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>complication</measure>
    <time_frame>30 days after operation</time_frame>
    <description>fever；wound infection；post-operation bleeding；ileus；stenosis；leakage</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1400</enrollment>
  <condition>Nutrition Disorders</condition>
  <arm_group>
    <arm_group_label>Preoperational nutrition support group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Scored patient-generated subjective global assessment(PG-SGA) ≥2，＜9 Oral enteral nutrition support（25 kcal/kg or 1.5 g protein/kg） for 3 days before operation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>PG-SGA ≥2，＜9</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>perioperational nutrition surpport</intervention_name>
    <description>Oral enteral nutrition support（25 kcal/kg or 1.5 g protein/kg） for 3 days before operation</description>
    <arm_group_label>Preoperational nutrition support group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A preoperative cancer stage of T2, T3, T4, Any N, M0 without digestive obstruction
             confirmed by whole body CT scan, which could be treated with laparoscopic gastrectomy;

          -  age 18-75 years;

          -  pathologic confirmation of gastric adenocarcinoma by endoscopic biopsy;

          -  normal hematological, renal, hepatic, and cardiac parameters,American Society of
             Anesthesiology (ASA) score &lt; III without severe systemic disease;

          -  no history of treatment with neoadjuvant chemotherapy and/or radiotherapy

          -  PG-SGA score ≥2，＜9

        Exclusion Criteria:

          -  patients requiring conversion to open gastrectomy

          -  excessive bleeding (˃ 500 mL);and patients opting out of the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 2, 2017</study_first_submitted>
  <study_first_submitted_qc>February 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 3, 2017</study_first_posted>
  <last_update_submitted>February 3, 2017</last_update_submitted>
  <last_update_submitted_qc>February 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>First Hospital of Jilin University</investigator_affiliation>
    <investigator_full_name>Quan Wang</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <keyword>gastric cancer</keyword>
  <keyword>Enhanced recovery after surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
    <mesh_term>Nutrition Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

